NCT05905367View on ClinicalTrials.gov

Symptom-inhibited Fentanyl Induction

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Opioid Use Disorder
Interventions
DRUG

Fentanyl

Symptom-inhibited IV fentanyl induction

DRUG

Methadone

Opioid agonist therapy (OAT) with methadone at starting doses established by symptom-inhibited IV fentanyl induction

DRUG

Slow-release oral morphine

Opioid agonist therapy (OAT) with SROM at starting doses established by symptom-inhibited IV fentanyl induction

Trial Locations (1)

V6A 1H2

RECRUITING

Hope to Health Research & Innovation Centre, Vancouver

All Listed Sponsors
lead

Pouya Azar

OTHER